V008-5274 Screening compound: 4-[4-(2-{4-[4-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl}-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)phenyl]morpholine

V008-5274 Screening compound: 4-[4-(2-{4-[4-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl}-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)phenyl]morpholine
V008-5274 Screening compound: 4-[4-(2-{4-[4-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl}-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)phenyl]morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound V008-5274
4-[4-(2-{4-[4-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl}-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)phenyl]morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V008-5274

Molecular Formula

C27H25F4N7O2 (C27 H25 F4 N7 O2)

Compound Name

4-[4-(2-{4-[4-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl}-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)phenyl]morpholine

IUPAC name

4-[4-(2-{4-[4-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl}-[124]triazolo[15-a]pyrimidin-7-yl)phenyl]morpholine

SMILES

O=C(c(cc1)c(C(F)(F)F)cc1F)N(CC1)CCN1c1nn2c(-c(cc3)ccc3N3CCOCC3)ccnc2n1

InChI

InChI=1S/C27H25F4N7O2/c28-19-3-6-21(22(17-19)27(29,30)31)24(39)36-9-11-37(12-10-36)26-33-25-32-8-7-23(38(25)34-26)18-1-4-20(5-2-18)35-13-15-40-16-14-35/h1-8,17H,9-16H2

InChI Key

NKPPVDNICSBDKC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19955098

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

555.54

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.999

Distribution Coefficient, logD

3.999

Water Solubility, LogSw

-4.33

Polar Surface Area

60.410

Acid Dissociation Constant (pKa)

20.52

Base Dissociation Constant (pKb)

8.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

V008-5274 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with V008-5274 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V008-5274?
Check Price and Availability of V008-5274, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V008-5274 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V008-5274
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V008-5274
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V008-5274 available by request